Broken String Biosciences appoints Steve Becker as Chief Commercial Officer
Appointment brings extensive experience to lead commercial operations and accelerate growth in key global markets
Broken String Biosciences and the Francis Crick Institute collaborate to advance ALS research
Partnership to expand applications of DNA break-mapping technology and advance understanding of genomic instability in development of the neurodegenerative disease amyotrophic lateral sclerosis
Broken String Biosciences appoints Gavin Burns as Vice President of Quality and Operations
Cambridge, UK: Broken String Biosciences, a genomics company that has built a technology platform to drive the development of cell and gene therapies that are safer by design, announces the appointment of Gavin Burns, PhD, as Vice President of Quality and Operations.
Broken String Biosciences’ INDUCE-seq platform demonstrates impact of structural DNA changes on specificity of CRISPR-Cas9 gene editing
Research published in Molecular Cell used INDUCE-seq to identify DNA topology as an important regulator of CRISPR targeting specificity Peer-reviewed data demonstrates the sensitivity of INDUCE-seq DNA break mapping platform, in identifying topology-related off-target ev
Broken String Biosciences strengthens senior leadership team to accelerate product development and commercialization
Cambridge, UK - Broken String Biosciences, a genomics company building a technology platform to drive the development of cell and gene therapies that are safer by design, announces the expansion of its senior leadership team with the appointments of Vincent Smith, PhD, as Chief Technology Officer and Jessica Rich as VP Business Development. Bringing significant expertise in their respective…
Broken String Biosciences closes $15M Series A funding round
Cambridge, UK - Broken String Biosciences (“Broken String”), a genomics company building a technology platform to drive the development of cell and gene therapies that are safer by design, today announced that it has closed a $15 million Series A investment round, co-led by Illumina Ventures and Mérieux Equity Partners, with contributions from HERAN Partners, and existing investors Tencent and…